Loading...

And this type of macular degeneration causes a gradual loss of vision from, it's caused from tiny fat deposits in proteins that destroy retinal pigment. Actually, it's the retina pigment epithelial cells, RPEs. Each participant receives a dose of 50,000 RPE stem cells by way of injection under the retina of the superior temporal macula. No adverse events happen. Each patient experienced improvement in their vision and one half procedure, the three patients who had the worst vision of them all were able to see an average of 21 more letters on the eye chart. The trial is now monitoring patients who received higher doses, 150,000 to 250,000 stem cells. If these doses prove safe, it will help determine if human testing can be scaled up. So something very positive there in the treatment of one particular form of vision loss.